Hookworm Disease Workup
- Author: David R Haburchak, MD, FACP; Chief Editor: Pranatharthi Haran Chandrasekar, MBBS, MD more...
Laboratory findings (eg, complete blood count [CBC]) may be consistent with iron-deficiency anemia. A differential count may reveal eosinophilia (1000-4000 cells/µL). Serologic tests (eg, tests for A caninum) are usually available only in research laboratories.
Stool should be examined for ova and parasites. The examination may demonstrate significant number of hookworm eggs. However, because egg laying may be delayed, stool examination should not be considered a sensitive test for identifying hookworm infection. Stool examinations may have to be repeated.
Progress is being made in polymerase chain reaction (PCR)-based methods for the specific diagnosis of hookworm infection.[31, 32]
Other causes of iron loss and blood loss should be excluded.
Anemia is confirmed by CBC and peripheral blood smear results that demonstrate signs typical of iron-deficiency anemia. Microscopy reveals hypochromic, microcytic red blood cells (RBCs).
Upon initial infection, eosinophilia is usually present during the migratory phase before stool findings are positive. Eosinophilia is surprisingly persistent and may be due to attachment of the adult worms to the intestinal mucosa. Peak eosinophil counts are 1350-3828 cells/µL at 5-9 weeks after experimental human exposure to 45-50 infective larvae. Eosinophilia can be a clue to hookworm, as well as Strongyloides infestation, in chronically infected patients.
Eosinophilia (along with raised serum immunoglobulin E [IgE] levels) is uncommon in cases of cutaneous larva migrans but is almost universally present in cases of eosinophilic enteritis.
The diagnosis is confirmed with direct microscopic analysis of fecal samples to verify the presence of hookworm eggs. The specimen is fixed in formalin and prepared as a wet mount.[4, 15]
During early infection, results of stool studies may be normal; in rare cases, the worm or larvae may be present in the fecal sample. In patients with mature infection, eggs may be seen during stool examination. If eggs are not seen, the likelihood of clinically significant infection is very low. When infection is suspected, stool should be evaluated promptly because eggs hatch into infective larvae within 24 hours.
Direct microscopic stool examination usually reveals ovoid eggs with thin colorless shells, measuring approximately 60 ´ 40 µm (see the image below). Under basic light microscopy, the eggs of N americanus and those of A duodenale appear morphologically similar. Larvae and adult worms can be distinguished by rearing filariform larvae in a fecal smear on a moist filter paper strip for 5-7 days (ie, Harada-Mori filter paper strip culture).
Distinguishing between N americanus and those of A duodenale is not critically important for choosing the type of anthelmintic drug to use, except that arrested larvae of A duodenale can enter breast milk and cause vertical transmission; these arrested larvae can also reactivate after initial treatment and again cause intestinal disease without reinfection.
Although hookworm eggs are easily distinguished from the eggs of other helminths, rhabditiform larvae are occasionally seen in old stool specimens (see the image below). Differentiating the larvae of Necator or Ancylostoma organisms from those of Strongyloides organisms requires attention to the unique morphologic features, particularly the relatively short buccal cavity and prominent genital primordium of Strongyloides larvae.
Various methods (eg, ether concentration or Kato-Katz thick smear) can be used for quantitative assessments. The worm burden may be estimated by counting the number of eggs per gram of stool, multiplying by the daily stool weight, and dividing the result by 25,000. A worm burden of less than 25 is generally subclinical; a burden of more than 500 worms is clinically significant.
In most cases, stool-concentration techniques are unnecessary, because most individuals with clinically significant infection excrete a large number of eggs. Eggs are easily detectable in unconcentrated specimens at levels of 1200/mL or higher. However, such techniques may be helpful for diagnosis of minimal infections expected during control programs. Because the intensity and prevalence of hookworm infection decrease with public health intervention, newer concentration methods (eg, FLOTAC) have some advantages over older methods.
In cases of cutaneous larva migrans, stool examination is not indicated, because the diagnosis can be made clinically and because the larvae remain confined to the skin in almost all cases. In cases of eosinophilic enteritis, no eggs are found, because adult A caninum worms do not produce eggs in human hosts.
In cases of severe infection, chest radiography may show diffuse alveolar infiltrates during the migration of the larvae through the lung. Once infection is established in the gut, imaging studies are not helpful.
In cases of eosinophilic enteritis, colonoscopy may reveal ileal and colonic ulceration and, occasionally, adult hookworms.
de Silva NR, Brooker S, Hotez PJ, Montresor A, Engels D, Savioli L. Soil-transmitted helminth infections: updating the global picture. Trends Parasitol. 2003 Dec. 19(12):547-51. [Medline].
Stoltzfus RJ, Dreyfuss ML, Chwaya HM, Albonico M. Hookworm control as a strategy to prevent iron deficiency. Nutr Rev. 1997 Jun. 55(6):223-32. [Medline].
World Health Organization. Parasitic Diseases. Available at http://www.who.int/vaccine_research/diseases/soa_parasitic/en/index2.html. Accessed: April 22, 2012.
Brooker S, Bundy DAP. Soil-transmitted Helminths (Geohelminths). Cook GC, Zumla AI, eds. Manson’s Tropical Diseases. 22nd ed. Philadelphia, PA: WB Saunders; 2009. 1515-48.
Centers for Disease Control and Prevention. Hookworm Infection. Available at http://www.cdc.gov/parasites/hookworm/index.html. Accessed: April 22, 2012.
Hotez PJ, Bethony J, Bottazzi ME, Brooker S, Buss P. Hookworm: "the great infection of mankind". PLoS Med. 2005 Mar. 2(3):e67. [Medline]. [Full Text].
Quinnell RJ, Pritchard DI, Raiko A, et al. Immune responses in human necatoriasis: association between interleukin-5 responses and resistance to reinfection. J Infect Dis. 2004 Aug 1. 190(3):430-8. [Medline].
Brooker S, Bethony J, Hotez PJ. Human hookworm infection in the 21st century. Adv Parasitol. 2004. 58:197-288. [Medline].
Bungiro R, Cappello M. Hookworm infection: new developments and prospects for control. Curr Opin Infect Dis. 2004 Oct. 17(5):421-6. [Medline].
Finlay CM, Walsh KP, Mills KH. Induction of regulatory cells by helminth parasites: exploitation for the treatment of inflammatory diseases. Immunol Rev. 2014 May. 259(1):206-30. [Medline].
Hotez PJ, Diemert D, Bacon KM, et al. The Human Hookworm Vaccine. Vaccine. 2013 Apr 18. 31 Suppl 2:B227-32. [Medline]. [Full Text].
Mason L, Tribolet L, Simon A, et al. Probing the equatorial groove of the hookworm protein and vaccine candidate antigen, Na-ASP-2. Int J Biochem Cell Biol. 2014 May. 50:146-55. [Medline].
Blair P, Diemert D. Update on prevention and treatment of intestinal helminth infections. Curr Infect Dis Rep. 2015 Mar. 17 (3):465. [Medline].
Capello M, Hotez PJ. Chapter 276: Intestinal Nematodes. SS, ed-in-chief; Pickering LK, Prober CG, eds. Long Principles and Practice of Pediatric Infectious Diseases. 3rd ed. Philadelphia, PA: Churchill Livingstone, an imprint of Elsevier Science; 2008. 1298-1300.
Centers for Disease Control and Prevention. Hookworm. CDC DPDx: Laboratory Identification of Parasites of Public Health Concern. Available at http://www.dpd.cdc.gov/DPDx/HTML/Hookworm.htm.
AAP. Hookworm infections. Red Book 2009: Report of the Committee on Infectious Diseases. 28th ed. American Academy of Pediatrics; 2009. 364(9450): 375-6.
Pullan RL, Smith JL, Jasrasaria R, Brooker SJ. Global numbers of infection and disease burden of soil transmitted helminth infections in 2010. Parasit Vectors. 2014 Jan 21. 7:37. [Medline].
Kabatereine NB, Tukahebwa EM, Kazibwe F, et al. Soil-transmitted helminthiasis in Uganda: epidemiology and cost of control. Trop Med Int Health. 2005 Nov. 10(11):1187-9. [Medline].
Hotez P. Hookworm and poverty. Ann N Y Acad Sci. 2008. 1136:38-44. [Medline].
Bhatia V, Das MK, Kumar P, Arora NK. Infantile hookworm disease. Indian Pediatr. 2010 Feb. 47(2):190-2. [Medline].
Hotez PJ, Brooker S, Bethony JM, et al. Hookworm infection. N Engl J Med. 2004 Aug 19. 351(8):799-807. [Medline].
Albonico M, Stoltzfus RJ, Savioli L, Tielsch JM, Chwaya HM, Ercole E, et al. Epidemiological evidence for a differential effect of hookworm species, Ancylostoma duodenale or Necator americanus, on iron status of children. Int J Epidemiol. 1998 Jun. 27(3):530-7. [Medline].
Ziegelbauer K, Speich B, Mäusezahl D, Bos R, Keiser J, Utzinger J. Effect of sanitation on soil-transmitted helminth infection: systematic review and meta-analysis. PLoS Med. 2012 Jan. 9(1):e1001162. [Medline]. [Full Text].
Gunawardena K, Kumarendran B, Ebenezer R, Gunasingha MS, Pathmeswaran A, de Silva N. Soil-transmitted helminth infections among plantation sector schoolchildren in Sri Lanka: prevalence after ten years of preventive chemotherapy. PLoS Negl Trop Dis. 2011 Sep. 5(9):e1341. [Medline]. [Full Text].
Feldmeier H, Schuster A. Mini review: Hookworm-related cutaneous larva migrans. Eur J Clin Microbiol Infect Dis. 2012 Jun. 31(6):915-8. [Medline].
Stoltzfus RJ, Albonico M, Tielsch JM, Chwaya HM, Savioli L. Linear growth retardation in Zanzibari school children. J Nutr. 1997 Jun. 127(6):1099-105. [Medline].
Heukelbach J, Feldmeier H. Epidemiological and clinical characteristics of hookworm-related cutaneous larva migrans. Lancet Infect Dis. 2008 May. 8(5):302-9. [Medline].
Stoltzfus RJ, Kvalsvig JD, Chwaya HM, Montresor A, Albonico M, Tielsch JM, et al. Effects of iron supplementation and anthelmintic treatment on motor and language development of preschool children in Zanzibar: double blind, placebo controlled study. BMJ. 2001 Dec 15. 323(7326):1389-93. [Medline]. [Full Text].
Stoltzfus RJ, Albonico M, Chwaya HM, Tielsch JM, Schulze KJ, Savioli L. Effects of the Zanzibar school-based deworming program on iron status of children. Am J Clin Nutr. 1998 Jul. 68(1):179-86. [Medline].
Hughes RG, Sharp DS, Hughes MC. Environmental influences on helminthiasis and nutritional status among Pacific schoolchildren. Int J Environ Health Res. 2004. 14(3):163-77.
Gasser RB, Cantacessi C, Loukas A. DNA technological progress toward advanced diagnostic tools to support human hookworm control. Biotechnol Adv. 2008 Jan-Feb. 26(1):35-45. [Medline].
Verweij JJ, Brienen EA, Ziem J, Yelifari L, Polderman AM, Van Lieshout L. Simultaneous detection and quantification of Ancylostoma duodenale, Necator americanus, and Oesophagostomum bifurcum in fecal samples using multiplex real-time PCR. Am J Trop Med Hyg. 2007 Oct. 77(4):685-90. [Medline].
Jelinek T, Maiwald H, Nothdurft HD, Löscher T. Cutaneous larva migrans in travelers: synopsis of histories, symptoms, and treatment of 98 patients. Clin Infect Dis. 1994 Dec. 19(6):1062-6. [Medline].
Utzinger J, Rinaldi L, Lohourignon LK, et al. FLOTAC: a new sensitive technique for the diagnosis of hookworm infections in humans. Trans R Soc Trop Med Hyg. 2008 Jan. 102(1):84-90. [Medline].
de Silva N, Guyatt H, Bundy D. Anthelmintics. A comparative review of their clinical pharmacology. Drugs. 1997 May. 53(5):769-88. [Medline].
Keiser J, Utzinger J. The drugs we have and the drugs we need against major helminth infections. Adv Parasitol. 2010. 73:197-230. [Medline].
Horton J. Albendazole: a review of anthelmintic efficacy and safety in humans. Parasitology. 2000. 121 Suppl:S113-32. [Medline].
Humphries D, Simms BT, Davey D, et al. Hookworm infection among school age children in Kintampo north municipality, Ghana: nutritional risk factors and response to albendazole treatment. Am J Trop Med Hyg. 2013 Sep. 89(3):540-8. [Medline]. [Full Text].
Keiser J, Utzinger J. Efficacy of current drugs against soil-transmitted helminth infections: systematic review and meta-analysis. JAMA. 2008 Apr 23. 299(16):1937-48. [Medline].
Steinmann P, Utzinger J, Du ZW, et al. Efficacy of single-dose and triple-dose albendazole and mebendazole against soil-transmitted helminths and Taenia spp.: a randomized controlled trial. PLoS One. 2011. 6(9):e25003. [Medline]. [Full Text].
Soukhathammavong PA, Sayasone S, Phongluxa K, et al. Low efficacy of single-dose albendazole and mebendazole against hookworm and effect on concomitant helminth infection in Lao PDR. PLoS Negl Trop Dis. 2012 Jan. 6(1):e1417. [Medline]. [Full Text].
Bethony J, Brooker S, Albonico M, et al. Soil-transmitted helminth infections: ascariasis, trichuriasis, and hookworm. Lancet. 2006 May 6. 367(9521):1521-32. [Medline].
Flohr C, Tuyen LN, Lewis S, et al. Poor sanitation and helminth infection protect against skin sensitization in Vietnamese children: A cross-sectional study. J Allergy Clin Immunol. 2006 Dec. 118(6):1305-11. [Medline].
Bennett A, Guyatt H. Reducing intestinal nematode infection: efficacy of albendazole and mebendazole. Parasitol Today. 2000 Feb. 16(2):71-4. [Medline].
Albonico M, Bickle Q, Ramsan M, et al. Efficacy of mebendazole and levamisole alone or in combination against intestinal nematode infections after repeated targeted mebendazole treatment in Zanzibar. Bull World Health Organ. 2003. 81(5):343-52. [Medline].
Schneider B, Jariwala AR, Periago MV, Gazzinelli MF, Bose SN, Hotez PJ, et al. A history of hookworm vaccine development. Hum Vaccin. 2011 Nov 1. 7(11):[Medline].
Xiao SH, Hui-Ming W, Tanner M, et al. Tribendimidine: a promising, safe and broad-spectrum anthelmintic agent from China. Acta Trop. 2005 Apr. 94(1):1-14. [Medline].
Stoltzfus RJ, Chway HM, Montresor A, Tielsch JM, Jape JK, Albonico M, et al. Low dose daily iron supplementation improves iron status and appetite but not anemia, whereas quarterly anthelminthic treatment improves growth, appetite and anemia in Zanzibari preschool children. J Nutr. 2004 Feb. 134(2):348-56. [Medline].
Le Huong T, Brouwer ID, Nguyen KC, Burema J, Kok FJ. The effect of iron fortification and de-worming on anaemia and iron status of Vietnamese schoolchildren. Br J Nutr. 2007 May. 97(5):955-62. [Medline].
Larocque R, Casapia M, Gotuzzo E, et al. A double-blind randomized controlled trial of antenatal mebendazole to reduce low birthweight in a hookworm-endemic area of Peru. Trop Med Int Health. 2006 Oct. 11(10):1485-95. [Medline].
Friis H, Mwaniki D, Omondi B, et al. Effects on haemoglobin of multi-micronutrient supplementation and multi-helminth chemotherapy: a randomized, controlled trial in Kenyan school children. Eur J Clin Nutr. 2003 Apr. 57(4):573-9. [Medline].
Bhatia V, Das MK, Kumar P, Arora NK. Infantile hookworm disease. Indian Pediatr. 2010 Feb. 47(2):190-2. [Medline].
Vercruysse J, Behnke JM, Albonico M, Ame SM, Angebault C, Bethony JM, et al. Assessment of the anthelmintic efficacy of albendazole in school children in seven countries where soil-transmitted helminths are endemic. PLoS Negl Trop Dis. 2011 Mar 29. 5(3):e948. [Medline]. [Full Text].
Soukhathammavong PA, Sayasone S, Phongluxa K, Xayaseng V, Utzinger J, Vounatsou P, et al. Low efficacy of single-dose albendazole and mebendazole against hookworm and effect on concomitant helminth infection in Lao PDR. PLoS Negl Trop Dis. 2012 Jan. 6(1):e1417. [Medline]. [Full Text].
Lone FW, Qureshi RN, Emanuel F. Maternal anaemia and its impact on perinatal outcome. Trop Med Int Health. 2004 Apr. 9(4):486-90. [Medline].
Brooker S, Hotez PJ, Bundy DA. Hookworm-related anaemia among pregnant women: a systematic review. PLoS Negl Trop Dis. 2008 Sep 17. 2(9):e291. [Medline]. [Full Text].
Imhoff-Kunsch B, Briggs V. Antihelminthics in pregnancy and maternal, newborn and child health. Paediatr Perinat Epidemiol. 2012 Jul. 26 Suppl 1:223-38. [Medline].
Bungiro R, Cappello M. Twenty-first century progress toward the global control of human hookworm infection. Curr Infect Dis Rep. 2011 Jun. 13(3):210-7. [Medline].
Kabatereine NB, Brooker S, Koukounari A, Kazibwe F, Tukahebwa EM, Fleming FM, et al. Impact of a national helminth control programme on infection and morbidity in Ugandan schoolchildren. Bull World Health Organ. 2007 Feb. 85(2):91-9. [Medline]. [Full Text].
Sakti H, Nokes C, Hertanto WS, Hendratno S, Hall A, Bundy DA, et al. Evidence for an association between hookworm infection and cognitive function in Indonesian school children. Trop Med Int Health. 1999 May. 4(5):322-34. [Medline].
McSorley HJ, Loukas A. The immunology of human hookworm infections. Parasite Immunol. 2010 Aug. 32(8):549-59. [Medline].
Cho Y, Vermeire JJ, Merkel JS, Leng L, Du X, Bucala R, et al. Drug repositioning and pharmacophore identification in the discovery of hookworm MIF inhibitors. Chem Biol. 2011 Sep 23. 18(9):1089-101. [Medline].
Diemert DJ, Bethony JM, Hotez PJ. Hookworm vaccines. Clin Infect Dis. 2008 Jan 15. 46(2):282-8. [Medline].
Hotez PJ, Zhan B, Bethony JM, Loukas A, Williamson A, Goud GN, et al. Progress in the development of a recombinant vaccine for human hookworm disease: the Human Hookworm Vaccine Initiative. Int J Parasitol. 2003 Sep 30. 33(11):1245-58. [Medline].
Loukas A, Bethony J, Brooker S, Hotez P. Hookworm vaccines: past, present, and future. Lancet Infect Dis. 2006 Nov. 6(11):733-41. [Medline].
Bethony JM, Simon G, Diemert DJ, Parenti D, Desrosiers A, Schuck S, et al. Randomized, placebo-controlled, double-blind trial of the Na-ASP-2 hookworm vaccine in unexposed adults. Vaccine. 2008 May 2. 26(19):2408-17. [Medline].
Tang H, Jin X, Li Y, et al. A large-scale screen for coding variants predisposing to psoriasis. Nat Genet. 2014 Jan. 46(1):45-50. [Medline].
Reddy M, Gill SS, Kalkar SR, et al. Oral drug therapy for multiple neglected tropical diseases: a systematic review. JAMA. 2007 Oct 24. 298(16):1911-24. [Medline].
Hotez PJ, Molyneux DH, Fenwick A, et al. Control of neglected tropical diseases. N Engl J Med. 2007 Sep 6. 357(10):1018-27. [Medline].
Easton AV, Oliveira RG, O'Connell EM, Kepha S, Mwandawiro CS, Njenga SM, et al. Multi-parallel qPCR provides increased sensitivity and diagnostic breadth for gastrointestinal parasites of humans: field-based inferences on the impact of mass deworming. Parasit Vectors. 2016 Jan 27. 9 (1):38. [Medline].